Saman Rasoul

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention

Vincent Roolvink, Borja Ibáñez, Jan Paul Ottervanger et al. · Journal of the American College of Cardiology · 2016 · 205 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)

Giuseppe De Luca, Sander A.J. Damen, Cyril Camaro et al. · EuroIntervention · 2019 · 185 citations

Medicine, Cardiology, Pharmacotherapy +17

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

Gregory G. Schwartz, Vera A. Bittner, Patricio López‐Jaramillo et al. · Journal of the American College of Cardiology · 2021 · 141 citations · Full text

Medicine, Cardiology, Pharmacology +17

Novel anti-inflammatory mechanisms of<i>N</i>-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage

Umesh C. Sharma, Nour-Eddine Rhaleb, Saraswati Pokharel et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2008 · 123 citations · Full text

Life Sciences, Immunology, Pharmacology +17